Introduction: Issues and viewpoints in pediatric psychopharmacology

International Review of Psychiatry

Volumn 20, Issue 2, 2008, Pages 119-120

  Riddle, Mark A ^a,c   Walkup, John T ^a   Vitiello, Benedetto ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; ATTENTION DEFICIT DISORDER; AUTISM; CHILD PSYCHIATRY; DRUG RESPONSE; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; PATIENT SAFETY; PEDIATRICS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUBLICATION; SHORT SURVEY;

ADOLESCENT; CHILD; HUMANS; MENTAL DISORDERS; PEDIATRICS; PSYCHOPHARMACOLOGY; SUICIDE;

EID: 41749094529     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260801887694     Document Type: Short Survey

References (2)

1. Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577-585.
2. Lipman, R. S. (1974). NIMH-PRB support of research in minimal brain dysfunction in children. In C.K. Conners (Ed.), Clinical Use of stimulant drugs in children (pp. 192-213). New York: American Elsevier Publishing Co.